-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AZCRLdAP2hz2pnDyoGTTSpslR5WoOvzIvMZi4I21JW1heBUhbB6TRr6aUv8t41uc DE+fy1iruYns0T3h+ARBLA== 0000950135-03-005736.txt : 20031119 0000950135-03-005736.hdr.sgml : 20031119 20031119113912 ACCESSION NUMBER: 0000950135-03-005736 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20031118 ITEM INFORMATION: Other events FILED AS OF DATE: 20031119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALKERMES CLINICAL PARTNERS LP CENTRAL INDEX KEY: 0001000688 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043145043 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26758 FILM NUMBER: 031012024 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940171 8-K 1 b48530ace8vk.txt ALKERMES CLINICAL PARTNERS, L.P. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------------------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 DATE OF REPORT - NOVEMBER 18, 2003 (Date of earliest event reported) ALKERMES CLINICAL PARTNERS, L.P. (Exact name of Registrant as specified in its charter) DELAWARE 0-26758 043-145043 (State of organization) (Commission file number) (IRS employer identification number)
88 SIDNEY STREET, CAMBRIDGE, MASSACHUSETTS 02139 (Address of principal executive offices, zip code) AREA CODE (617) 494-0171 (Telephone number) ITEM 5. OTHER EVENTS. The Limited Partners of Alkermes Clinical Partners, L.P. met today and voted to adjourn the scheduled Special Meeting of Limited Partners until 10:00 a.m., local time, on December 9, 2003. The Special Meeting will reconvene at the offices of Alkermes, Inc., 88 Sidney Street, Cambridge, Massachusetts 02139 for the following purposes: 1. To consider and vote upon a proposal to terminate Alkermes Clinical Partners, L.P. pursuant to Section 9.1 of the Alkermes Clinical Partners, L.P. Agreement of Limited Partnership, dated February 7, 1992, as amended, among Alkermes Development Corporation, II, a Delaware corporation, the Initial Limited Partner and Additional Limited Partners. 2. To transact such other business as may properly come before the meeting. Only holders of record of Alkermes Clinical Partners, L.P. limited partnership interests at the close of business on October 2, 2003 are entitled to vote at the adjourned Special Meeting or any subsequent adjournments or postponements thereof. Approval of the termination proposal at the Special Meeting requires the favorable vote of the holders of at least two-thirds in interest of the Limited Partners in person or by proxy. SIGNATURES Pursuant to requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: November 18, 2003 Alkermes Clinical Partners, L.P. By: /s/ James M. Frates ------------------- James M. Frates Chief Financial Officer, Vice President, Treasurer and Assistant Secretary -----END PRIVACY-ENHANCED MESSAGE-----